Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report - Poll - MDSpire

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

  • By

  • Fang Yang

  • Linli Xuan

  • Jun Li

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Severe IL-6–dominant immune-mediated inflammatory response complicated by probable arginine vasopressin deficiency following ivonescimab-based therapy in advanced EGFR-mutant lung squamous cell carcinoma: a case report

  • by Fang Yang, Linli Xuan, Jun Li

  • May 25, 2026

Related Content

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Management of toxicities from antibody – drug conjugates in breast cancer